Axonics Inc
(FRA:0I3)
€
61
0 (0%)
Market Cap: 3.29 Bil
Enterprise Value: 3.00 Bil
PE Ratio: 0
PB Ratio: 5.57
GF Score: 84/100 Axonics Modulation Technologies Inc at Barclays Global Healthcare Conference (Virtual) Transcript
Mar 10, 2021 / 03:55PM GMT
Release Date Price:
€46.8
(+0.86%)
Travis Steed
Good morning, everybody. This is Travis Steed. I'm the Medical Device Analyst at Barclays. And up next, we have Axonics. Very pleased to welcome Ray Cohen, CEO; Dearen, President and CFO; and then Neil Bhalodkar, Head of Investor Relations. Welcome, and thanks, and hopefully, next year we'll be in person in Miami, but for now, we'll do this virtually over Zoom.
Raymond W. Cohen
Axonics Modulation Technologies, Inc. - CEO & Director
Thanks for having us.
Danny L. Dearen
Axonics Modulation Technologies, Inc. - President & CFO
Thanks for inviting us.
Questions & Answers
Travis Steed;Raymond W. Cohen
Axonics
Of course. So Ray, I just wanted to start out, the recent acquisition that you did with Bulkamid, usually, single product companies at the beginning of their growth opportunity, make a sizable acquisition in adjacent area. So just wanted to start off give some overview of like Bulkamid, why that product then and why now?
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot